nVerses Capital’s CME Group CME Stock Holding History

nVerses Capital’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$19.7K	–	1059
2024 Q2	$19.7K	Buy	+100	New	+$20.7K	0.01%	798

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

nVerses Capital's CME Position: Q3 2024 in Review

nVerses Capital sold out of CME Group (CME) in Q3 2024, closing a stake of 100 shares — an estimated $19.7K sold.

nVerses Capital first reported a position in CME in Q2 2024 and held it in 1 quarter. The position peaked at $19.7K in Q2 2024. 1,390 funds tracked by Wall St. Rank hold CME as of Q3 2024.

nVerses Capital reported no remaining CME Group position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 100 CME Group shares in Q3 2024, an estimated $19.7K.
nVerses Capital first reported a position in CME Group in Q2 2024 and held it in 1 quarter.
nVerses Capital's CME Group position peaked at $19.7K in Q2 2024.
1,390 funds tracked by Wall St. Rank held CME Group as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.